共 102 条
[1]
Allen CE(2015)How I treat Langerhans cell histiocytosis Blood 126 26-35
[2]
Laddish S(2010)Recurrent BRAF mutations in Langerhans cell histiocytosis Blood 116 1919-1923
[3]
McClain KL(2018)Langerhans cell histiocytosis: a neoplastic disorder driven by Ras-ERK pathway mutations J Am Acad Dermatol 78 579-590.e4
[4]
Badalian-Very G(2013)Histiocyte Society. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis Blood 121 5006-5014
[5]
Vergilio JA(2013)Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years Pediatr Blood Cancer 60 175-184
[6]
Degar BA(2014)Meeting report updates on histiocytic disorders Pediatr Blood Cancer 61 1329-1335
[7]
Tran G(2012)Medical management of Langerhans cell histiocytosis from diagnosis to treatment Expert Opin Pharmacother 13 1309-1322
[8]
Huynh TN(2012)Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome J Pediatr 161 129-133
[9]
Paller AS(2015)Histiocytic disorders of the chest: imaging findings Radiographics 35 357-370
[10]
Gadner H(2006)Adult pulmonary Langerhans’ cell histiocytosis Eur Respir J 27 1272-1285